More Like this

1. Recent trends in machine learning and deep learning-based prediction of G-protein coupled receptor-ligand binding affinities

   https://doi.org/10.3389/fbinf.2025.1712577  

   Stephenson, Joshua; Karnati, Konda Reddy (January 2026, Frontiers in Bioinformatics)

   Accurately predicting protein-ligand binding affinity is key in drug discovery. Machine Learning and Deep Learning methods used in the drug discovery process have advanced the prediction of drug–target binding affinities, particularly for G protein–coupled receptors (GPCRs), a pharmacologically significant yet structurally heterogeneous protein family. In this review, binding affinity prediction models are examined and organized according to sequence-based one-dimensional, graph-based two-dimensional, and structure-based three-dimensional frameworks. Sequence-based models utilize convolutional neural networks for high-throughput screening. Recently published models incorporated attention mechanisms and self-supervised learning, enhancing interpretability and reducing dependence on annotated datasets. Graph-based models employ graph neural networks and molecular contact maps to capture topological features, enabling substructure-sensitive predictions. Structure-based approaches integrate spatial and conformational data into high-resolution interaction models. The hybrid use of these three approaches could significantly increase the success rate ofin silicomodels for drug discovery, particularly for GPCRs. 

   more » « less
2. A geometric graph-based deep learning model for drug-target affinity prediction

   https://doi.org/10.1186/s12859-025-06347-2  

   Rana, Md Masud; Mukta, Farjana Tasnim; Nguyen, Duc D (December 2026, BMC Bioinformatics)

   Abstract In structure-based drug design, accurately estimating the binding affinity between a candidate ligand and its protein receptor is a central challenge. Recent advances in artificial intelligence, particularly deep learning, have demonstrated superior performance over traditional empirical and physics-based methods for this task, enabled by the growing availability of structural and experimental affinity data. In this work, we introduce DeepGGL, a deep convolutional neural network that integrates residual connections and an attention mechanism within a geometric graph learning framework. By leveraging multiscale weighted colored bipartite subgraphs, DeepGGL effectively captures fine-grained atom-level interactions in protein-ligand complexes across multiple scales. We benchmarked DeepGGL against established models on CASF-2013 and CASF-2016, where it achieved state-of-the-art performance with significant improvements across diverse evaluation metrics. To further assess robustness and generalization, we tested the model on the CSAR-NRC-HiQ dataset and the PDBbind v2019 holdout set. DeepGGL consistently maintained high predictive accuracy, highlighting its adaptability and reliability for binding affinity prediction in structure-based drug discovery. 

   more » « less
3. Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions

   https://doi.org/10.1093/bib/bbab476  

   Dhakal, Ashwin; McKay, Cole; Tanner, John J; Cheng, Jianlin (January 2022, Briefings in Bioinformatics)

   Abstract New drug production, from target identification to marketing approval, takes over 12 years and can cost around $2.6 billion. Furthermore, the COVID-19 pandemic has unveiled the urgent need for more powerful computational methods for drug discovery. Here, we review the computational approaches to predicting protein–ligand interactions in the context of drug discovery, focusing on methods using artificial intelligence (AI). We begin with a brief introduction to proteins (targets), ligands (e.g. drugs) and their interactions for nonexperts. Next, we review databases that are commonly used in the domain of protein–ligand interactions. Finally, we survey and analyze the machine learning (ML) approaches implemented to predict protein–ligand binding sites, ligand-binding affinity and binding pose (conformation) including both classical ML algorithms and recent deep learning methods. After exploring the correlation between these three aspects of protein–ligand interaction, it has been proposed that they should be studied in unison. We anticipate that our review will aid exploration and development of more accurate ML-based prediction strategies for studying protein–ligand interactions. 

   more » « less
4. Assessing the potential of deep learning for protein–ligand docking

   https://doi.org/10.1038/s42256-025-01160-1  

   Morehead, Alex; Giri, Nabin; Liu, Jian; Neupane, Pawan; Cheng, Jianlin (January 2026, Nature Machine Intelligence)

   Abstract The effects of ligand binding on protein structures and their in vivo functions carry numerous implications for modern biomedical research and biotechnology development efforts such as drug discovery. Although several deep learning (DL) methods and benchmarks designed for protein–ligand docking have recently been introduced, so far no previous works have systematically studied the behaviour of the latest docking and structure prediction methods within the broadly applicable context of: (1) using predicted (apo) protein structures for docking (for example, for applicability to new proteins); (2) binding multiple (cofactor) ligands concurrently to a given target protein (for example, for enzyme design); and (3) having no previous knowledge of binding pockets (for example, for generalization to unknown pockets). To enable a deeper understanding of the real-world utility of docking methods, we introduce PoseBench, a comprehensive benchmark for broadly applicable protein–ligand docking. PoseBench enables researchers to rigorously and systematically evaluate DL methods for apo-to-holo protein–ligand docking and protein–ligand structure prediction using both primary ligand and multiligand benchmark datasets, the latter of which we introduce to the DL community. Empirically, using PoseBench, we find that: (1) DL cofolding methods generally outperform comparable conventional and DL docking baseline algorithms, but popular methods such as AlphaFold 3 are still challenged by prediction targets with new protein–ligand binding poses; (2) certain DL cofolding methods are highly sensitive to their input multiple sequence alignments, whereas others are not; and (3) DL methods struggle to strike a balance between structural accuracy and chemical specificity when predicting new or multiligand protein targets. 

   more » « less
5. Are 2D fingerprints still valuable for drug discovery?

   https://doi.org/10.1039/D0CP00305K  

   Gao, Kaifu; Nguyen, Duc Duy; Sresht, Vishnu; Mathiowetz, Alan M.; Tu, Meihua; Wei, Guo-Wei (April 2020, Physical Chemistry Chemical Physics)

   Recently, molecular fingerprints extracted from three-dimensional (3D) structures using advanced mathematics, such as algebraic topology, differential geometry, and graph theory have been paired with efficient machine learning, especially deep learning algorithms to outperform other methods in drug discovery applications and competitions. This raises the question of whether classical 2D fingerprints are still valuable in computer-aided drug discovery. This work considers 23 datasets associated with four typical problems, namely protein–ligand binding, toxicity, solubility and partition coefficient to assess the performance of eight 2D fingerprints. Advanced machine learning algorithms including random forest, gradient boosted decision tree, single-task deep neural network and multitask deep neural network are employed to construct efficient 2D-fingerprint based models. Additionally, appropriate consensus models are built to further enhance the performance of 2D-fingerprint-based methods. It is demonstrated that 2D-fingerprint-based models perform as well as the state-of-the-art 3D structure-based models for the predictions of toxicity, solubility, partition coefficient and protein–ligand binding affinity based on only ligand information. However, 3D structure-based models outperform 2D fingerprint-based methods in complex-based protein–ligand binding affinity predictions. 

   more » « less